Vivos Historical Balance Sheet

VVOS Stock  USD 4.55  0.06  1.30%   
Trend analysis of Vivos Therapeutics balance sheet accounts such as Total Assets of 18.2 M, Short Long Term Debt Total of 2.1 M, Other Current Liabilities of 2.2 M or Total Current Liabilities of 7.5 M provides information on Vivos Therapeutics' total assets, liabilities, and equity, which is the actual value of Vivos Therapeutics to its prevalent stockholders. By breaking down trends over time using Vivos Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Vivos Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vivos Therapeutics is a good buy for the upcoming year.

Vivos Therapeutics Inventory

0.95

  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivos Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Vivos Stock please use our How to Invest in Vivos Therapeutics guide.

About Vivos Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Vivos Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Vivos Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Vivos Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Vivos currently owns. An asset can also be divided into two categories, current and non-current.

Vivos Therapeutics Balance Sheet Chart

At this time, Vivos Therapeutics' Other Assets are comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 18.2 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 390.4 K in 2024.

Total Assets

Total assets refers to the total amount of Vivos Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Vivos Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Vivos Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Vivos Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.
Most accounts from Vivos Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Vivos Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivos Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Vivos Stock please use our How to Invest in Vivos Therapeutics guide.At this time, Vivos Therapeutics' Other Assets are comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 18.2 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 390.4 K in 2024.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total1.6M2.4M2.0M2.1M
Total Assets33.7M13.7M10.7M18.2M

Vivos Therapeutics balance sheet Correlations

0.240.840.610.830.580.680.270.61-0.92-0.480.270.94-0.030.470.49-0.590.940.72-0.60.670.49-0.320.880.650.51
0.240.520.88-0.210.560.40.480.860.03-0.60.710.10.290.750.77-0.80.10.09-0.820.470.710.390.470.530.9
0.840.520.860.50.740.810.490.83-0.68-0.740.670.740.170.710.75-0.880.740.47-0.880.90.810.10.870.830.82
0.610.880.860.160.710.660.520.98-0.37-0.740.760.480.220.860.9-0.950.480.34-0.970.760.840.250.760.740.98
0.83-0.210.50.160.150.3-0.030.17-0.97-0.02-0.160.94-0.290.140.08-0.090.940.84-0.090.360.05-0.60.60.30.04
0.580.560.740.710.150.960.890.69-0.27-0.980.850.340.740.290.4-0.870.34-0.06-0.810.850.910.530.760.950.77
0.680.40.810.660.30.960.830.66-0.41-0.950.770.460.660.290.39-0.820.460.02-0.780.90.870.430.830.960.7
0.270.480.490.52-0.030.890.830.52-0.03-0.90.870.090.930.080.14-0.680.09-0.28-0.60.790.850.770.590.890.63
0.610.860.830.980.170.690.660.52-0.37-0.730.710.480.230.870.89-0.920.480.34-0.950.740.80.20.820.730.95
-0.920.03-0.68-0.37-0.97-0.27-0.41-0.03-0.370.170.0-0.990.28-0.35-0.310.3-0.99-0.870.3-0.5-0.220.52-0.71-0.42-0.25
-0.48-0.6-0.74-0.74-0.02-0.98-0.95-0.9-0.730.17-0.91-0.24-0.76-0.36-0.460.9-0.240.150.85-0.87-0.95-0.63-0.73-0.94-0.81
0.270.710.670.76-0.160.850.770.870.710.0-0.910.090.720.430.51-0.880.09-0.19-0.830.840.970.790.540.860.86
0.940.10.740.480.940.340.460.090.48-0.99-0.240.09-0.240.450.41-0.391.00.88-0.410.560.31-0.470.760.490.36
-0.030.290.170.22-0.290.740.660.930.230.28-0.760.72-0.24-0.23-0.14-0.44-0.24-0.59-0.350.530.650.850.290.680.37
0.470.750.710.860.140.290.290.080.87-0.35-0.360.430.45-0.230.98-0.710.450.5-0.780.480.51-0.060.560.370.79
0.490.770.750.90.080.40.390.140.89-0.31-0.460.510.41-0.140.98-0.790.410.4-0.850.520.580.010.580.430.84
-0.59-0.8-0.88-0.95-0.09-0.87-0.82-0.68-0.920.30.9-0.88-0.39-0.44-0.71-0.79-0.39-0.130.99-0.85-0.94-0.43-0.76-0.86-0.97
0.940.10.740.480.940.340.460.090.48-0.99-0.240.091.0-0.240.450.41-0.390.88-0.410.560.31-0.470.760.490.36
0.720.090.470.340.84-0.060.02-0.280.34-0.870.15-0.190.88-0.590.50.4-0.130.88-0.180.21-0.01-0.70.480.10.19
-0.6-0.82-0.88-0.97-0.09-0.81-0.78-0.6-0.950.30.85-0.83-0.41-0.35-0.78-0.850.99-0.41-0.18-0.8-0.9-0.35-0.76-0.8-0.98
0.670.470.90.760.360.850.90.790.74-0.5-0.870.840.560.530.480.52-0.850.560.21-0.80.920.440.830.960.79
0.490.710.810.840.050.910.870.850.8-0.22-0.950.970.310.650.510.58-0.940.31-0.01-0.90.920.640.70.940.91
-0.320.390.10.25-0.60.530.430.770.20.52-0.630.79-0.470.85-0.060.01-0.43-0.47-0.7-0.350.440.640.010.50.42
0.880.470.870.760.60.760.830.590.82-0.71-0.730.540.760.290.560.58-0.760.760.48-0.760.830.70.010.840.71
0.650.530.830.740.30.950.960.890.73-0.42-0.940.860.490.680.370.43-0.860.490.1-0.80.960.940.50.840.79
0.510.90.820.980.040.770.70.630.95-0.25-0.810.860.360.370.790.84-0.970.360.19-0.980.790.910.420.710.79
Click cells to compare fundamentals

Vivos Therapeutics Account Relationship Matchups

Vivos Therapeutics balance sheet Accounts

201920202021202220232024 (projected)
Total Assets7.6M25.3M33.7M13.7M10.7M18.2M
Short Long Term Debt Total3.7M1.3M1.6M2.4M2.0M2.1M
Other Current Liab1.4M3.2M2.9M1.6M2.5M2.2M
Total Current Liabilities9.1M7.8M7.5M6.8M7.3M7.5M
Total Stockholder Equity(2.9M)16.9M25.5M4.8M411K390.5K
Property Plant And Equipment Net1.1M871.6K2.8M4.8M4.7M2.9M
Current Deferred Revenue2.9M2.9M2.4M2.9M2.1M2.6M
Net Debt3.2M(16.9M)(22.4M)(1.1M)352K369.6K
Retained Earnings(23.3M)(35.3M)(55.6M)(79.5M)(93.1M)(88.4M)
Accounts Payable1.1M781K920K1.4M2.1M1.2M
Cash469.4K18.2M24.0M3.5M1.6M1.6M
Non Current Assets Total5.6M4.9M6.4M8.3M8.3M7.3M
Non Currrent Assets Other1.1M1.1M356K374K307K433.5K
Cash And Short Term Investments469.4K18.2M24.0M3.5M1.6M1.6M
Net Receivables956.0K1.5M1.7M457K202K191.9K
Common Stock Shares Outstanding727.7K728.4K849.3K920.5K1.2M899.6K
Liabilities And Stockholders Equity7.6M25.3M33.7M13.7M10.7M18.2M
Non Current Liabilities Total1.4M587.1K641K2.1M3.0M1.6M
Other Current Assets295.0K1.3M1.6M1.4M616K997.7K
Other Stockholder Equity20.3M50.8M81.2M84.3M93.5M63.7M
Total Liab10.5M8.4M8.2M8.9M10.3M9.1M
Net Invested Capital766.5K18.2M26.8M4.8M411K390.5K
Property Plant And Equipment Gross1.1M871.6K4.1M6.5M7.0M3.8M
Total Current Assets2.0M20.4M27.3M5.4M2.5M2.3M
Net Working Capital(7.1M)12.6M19.8M(1.4M)(4.8M)(4.6M)
Short Term Debt3.7M867.0K1.3M838K474K450.3K
Intangible Assets689.2K270.1K341K302K420K421.7K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vivos Stock Analysis

When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.